In addition to higher EZH2 expression, poor angiogenesis is also a well characterized predictor for Sunitinib resistance (34, 35), and we thus analyzed the angiogenesis score in CIN25 subtypes of ccRCC tumors. Here, EZH2 is linked to nonpapillary renal cell carcinoma.